OICHARTS
8 AMThe 8 AM report →

TVGN

Tevogen Inc. Common Stock · XNAS · 130 sessions on record
$6.62▼ −0.13 · −1.9%from $6.75 the session before · Sep 30, 2026 close · end of day
Open
$6.57
High
$7.23
Low
$6.57
Day's range
$0.669.8% of the previous close
VWAP
$6.83close −3.1% from it
Volume, shares
1.93K0.22× the 20-session average
Traded, $
$13.2K
Trades
2009.6 shares per trade
Previous close
$6.75−0.13 to the close
Market cap
$43.1Mat the close of Sep 30
Day range8% of the way up
$6.57$7.23
52-week range36% of the way up
$3.64 Jul 20$12.03 Jun 12

−45% from the high · +82% from the low

Options

No listed options on TVGN

Close $ · S&P 500 rebased to the first close126 sessions to Sep 30 · axis fixed at 4 × ATR-14 around the last close
130 sessions on file · from Mar 25
TVGN close over the last 126 sessions, with S&P 500 rebased to the first close3.897.7811.67axis spans 200%S&P 500TVGNMar 31Jul 1Sep 30126 sessions from Mar 31 to Sep 30; the price axis spans 200 percent.

Quarterly results

consolidated · latest filed Aug 14, 2026 · SEC filings

Profit −$5.8M in the Jun 2026 quarter, consolidated.

Last 8 quarters, consolidatedUS dollars as filed · year on year against the same quarter a year earlier · market: close on the first session after the filing against the last close before it, S&P 500 over the same session
Quarterly results of TVGN on the consolidated basis with the market's move on the first session after each filing
QuarterRevenue $Revenue YoYProfit $Profit YoYEPS $Market on the day
Jun 2026filed Aug 14——−$5.8M—-1.52▼ −4.2%S&P 500 −0.5% · −3.7 pp
Mar 2026filed Aug 14——−$5.4M—-1.61▼ −4.2%S&P 500 −0.5% · −3.7 pp
Dec 2025filed Mar 31——−$4.7M—-3.09▼ −0.9%S&P 500 +0.8% · −1.6 pp
Sep 2025filed Nov 14——−$5.7M—-0.03—not reached
Jun 2025filed Aug 14——−$5.5M—-1.71▼ −4.2%S&P 500 −0.5% · −3.7 pp
Mar 2025filed Aug 14——−$10.4M▼ −190%-3.25▼ −4.2%S&P 500 −0.5% · −3.7 pp
Dec 2024filed Apr 2——−$9.4M▼ −120%0.26—not reached
Sep 2024filed Nov 14——−$5.9M—-0.03—not reached
By fiscal yearfiscal years as filed in the 10-K · named by the year the fiscal year ends
Financial-year results of TVGN on the consolidated basis, summed from the quarters filed
YearRevenue $Revenue YoYProfit $Profit YoYEPS $
FY25to Dec 2025——−$26.3M—-8.08
FY24to Dec 2024——−$13.7M—-3.50
FY23to Dec 2023——−$60.5M▼ −1,500%-2.44
FY22to Dec 2022——$4.4M——

Fundamentals

consolidated · filings to Jun 2026 · close $6.62 on Sep 30

market cap $43.1M.

Valuation
Market cap
$43.1Mon Sep 30
Price to earnings
—
Trailing EPS
$-6.25diluted · consolidated · four quarters to Jun 2026
Price to book
—
Book value a share
—
Debt to equity
—
Return on equity
—
Dividend yield
—
Price to sales
—
Shares outstanding
6.51Mon Sep 30
Growthsums of the four quarters filed to Jun 2026 · growth against the four quarters before them · consolidated
Revenue, trailing 12 months
—
Revenue growth, 12 months
—
Revenue 3-year CAGR
—trailing twelve months against the twelve months 3 years earlier · consolidated
Profit, trailing 12 months
−$21.6Mfour quarters to Jun 2026
Profit growth, 12 months
—
Profit 3-year CAGR
—
PeersBiological Products, (No Diagnostic Substances) · the ten largest by market cap · industry P/E needs two stocks with trailing profit and a market cap
Stocks in the industry Biological Products, (No Diagnostic Substances) with market cap, price to earnings and price to book
StockMarket capP/EP/BClose $
MRNAModerna, Inc. Common Stock$76.88Bon Sep 30—11$192.57
HALOHalozyme Therapeutics, Inc.$12.53Bon Sep 3032consolidated87$110.40
TECHBio-Techne Corp.$11.36Bon Sep 3062consolidated5.4$72.47
KODKodiak Sciences Inc Common Stock$5.96Bon Sep 30—98$94.80
ALLOAllogene Therapeutics, Inc. Common Stock$552.8Mon Sep 30—1.3$1.60
DTILPrecision BioSciences, Inc. Common Stock$172.8Mon Sep 30—3.8$6.26
OTLKOutlook Therapeutics, Inc. Common Stock$139.6Mon Sep 30——$0.57
BSEMBioStem Technologies, Inc. Common Stock$55.2Mon Sep 30—2.0$3.09
TVGNTevogen Inc. Common Stock$43.1Mon Sep 30——$6.62
BCDABioCardia, Inc. Common Stock$15.3Mon Sep 30—5.7$1.01

Shareholding

SEC Forms 3, 4 and 5

No open-market insider buying or selling in the last 90 days.

Insider tradesSEC Forms 3, 4 and 5 · the latest 3
TVGN insider trades
InsiderTradeSharesPriceHeld after
Flomenberg NealOfficersold · Mar 13, 2026501$6.4076,940
Flomenberg NealOfficersold · Mar 10, 202619$7.7577,893
Flomenberg NealOfficersold · Mar 11, 2026452$7.2677,441

Corporate actions

exchange records

No corporate action on record for TVGN yet.

Price history

130 sessions on record · to Sep 30 · end of day

TVGN is −5.2% over 20 sessions against the S&P 500's −0.6%, 45% below its 52-week high, realised volatility 51% annualised.

Returns against S&P 500longest window first · S&P 500 over the same sessions
Returns of the stock and S&P 500 over six windows, longest first
WindowFrom $TVGN %S&P 500 %Difference pp
120 sessionssince Apr 8$5.81▲ +14%▲ +13%+1.1
60 sessionssince Jul 6$5.86▲ +13%▲ +1.5%+11
20 sessionssince Aug 31$6.98▼ −5.2%▼ −0.58%−4.6
5 sessionssince Sep 22$7.81▼ −15%▼ −1.4%−14
1 sessionsince Sep 29$6.75▼ −1.9%▼ −0.21%−1.7
Averages of the closeclose against each average
5-session average
$7.05close −6.1% from it
20-session average
$7.36close −10% from it
50-session average
$6.71close −1.3% from it
Range and volumetrue range over 14 sessions · high to low over 20 · volume against the 20-session average
Average true range, 14
$0.558.3% of the close
Average day's range, 20
$0.426.3% of the close
Volume against 20 sessions
0.22×1.93K vs 8.49K average
Volatility and co-movement with S&P 500annualised from daily returns
Realised volatility, 20
51%≈ ±3.2% a session · moved more than that on 4 of 20
Realised volatility, 60
81%≈ ±5.1% a session · moved more than that on 14 of 60
Beta to S&P 500, 60
0.81moved with S&P 500 on 31 of 60 sessions
Up and down sessionscloses above and below the previous close
Last 20 sessions
10 up · 8 downof 18
Last 60 sessions
31 up · 27 downof 58
Best session, 250
▲ +39%May 14
Worst session, 250
▼ −27%Jun 26

Short-sale volume

25 sessions · to Sep 30, 2026

Short sales were 25% of reported volume on Sep 30, 2026, against 34% over the last 25 sessions.

Last 10 sessionsshare of the day's reported volume
TVGN daily short-sale volume
SessionShort volumeReported volumeShort share
Sep 30, 202619778025.3%
Sep 29, 20263018816.0%
Sep 28, 20261.61K5.4K29.7%
Sep 25, 20261.46K3.41K42.9%
Sep 24, 20263001.46K20.6%
Sep 23, 2026121408.6%
Sep 22, 202613673918.4%
Sep 21, 20266962211.1%
Sep 18, 202624287327.8%
Sep 17, 20263691.03K35.9%

Filings

SEC EDGAR · newest first
TVGN SEC filings
FiledFormReport date
Sep 30, 20268-KSep 29, 2026
Sep 16, 20268-KSep 14, 2026
Sep 16, 2026SCHEDULE 13D/A—
Sep 16, 2026SCHEDULE 13D/A—
Sep 16, 20264Sep 14, 2026
Sep 16, 20264Sep 14, 2026
Sep 15, 20264Sep 11, 2026
Sep 15, 20264Sep 11, 2026
Sep 15, 20264Sep 11, 2026
Sep 15, 20264Sep 11, 2026
Sep 15, 20264Sep 11, 2026
Sep 10, 20268-KSep 9, 2026
Aug 26, 20268-KAug 24, 2026
Aug 24, 2026S-8—
Aug 14, 202610-QJun 30, 2026
Aug 3, 2026DEF 14AAug 3, 2026
Jul 30, 20268-KJul 29, 2026
Jul 23, 2026PRE 14AJul 23, 2026
Jul 14, 2026SCHEDULE 13D/A—
Jul 10, 2026S-8—
Jul 10, 20264Jul 10, 2026
Jul 10, 20264Jul 10, 2026
Jul 10, 20264Jul 10, 2026
Jul 10, 20264Jul 10, 2026
Jul 10, 20264Jul 10, 2026

About Tevogen Inc. Common Stock

SEC and exchange records
Company
Tevogen Inc. Common Stock
Exchange
XNAS
Industry
Biological Products, (No Diagnostic Substances) · SEC standard industrial classification
SEC CIK
1860871
Sessions on record
130
Price source
End of day · delayed
Computed
1 Oct, 10:42 pm IST

OI Charts is not a registered investment adviser or broker-dealer. Prices, filings and open interest are public data and arithmetic on it, not a basis for any investment decision.